Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Appointed director
CC transcript
Inv. presentation
Cert. of designation
Director departure
Asset disposition
Notes underwriting agrmnt

Rennova Health, Inc. (RNVA) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/21/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "RENNOVA HEALTH, INC. PROVIDES UPDATE AFTER FILING 2023 SECOND QUARTER FINANCIAL STATEMENTS",
"Speakers: Kevin Davis and Seamus Lagan"
04/24/2023 8-K Quarterly results
02/23/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "RENNOVA HEALTH, INC. PROVIDES UPDATE ON 2022 FINANCIALS AND MYRTLE RECOVERY CENTERS WEST PALM BEACH, Fla. – Rennova Health, Inc. Chief Executive Officer Seamus Lagan recently joined Stock Day host Everett Jolly to provide an update on 2022 financial statements and other activities.",
"Rennova Health, Inc. Interview CEO Seamus Lagan on Uptick Newswire – February 2023 Speakers: Everett Jolly and Seamus Lagan"
11/23/2022 8-K Quarterly results
10/20/2022 8-K Quarterly results
09/23/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
09/14/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "RENNOVA HEALTH, INC. PROVIDES BUSINESS UPDATE WEST PALM BEACH, Fla. – Rennova Health, Inc. Chief Executive Officer Seamus Lagan joined Stock Day host Everett Jolly to provide an update on the business and future plans.",
"RENNOVA HEALTH INTERVIEW CEO SEAMUS LAGAN ON UPTICK NEWSWIRE SEPTEMBER 2022"
06/16/2022 8-K Quarterly results
04/27/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "RENNOVA HEALTH, INC. DISCUSSES 2021 FINANCIAL RESULTS AND COMPANY PROGRESS WITH THE STOCK DAY PODCAST WEST PALM BEACH, Fla. – Rennova Health, Inc. Chief Executive Officer Seamus Lagan joined Stock Day host Everett Jolly to discuss its 2021 financial results and provide an update on the business.",
"Rennova Health Interview CEO Seamus Lagan on Uptick Newswire April 2022"
04/07/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
03/16/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation ...
Docs: "RENNOVA HEALTH, INC. COMPLETES REVERSE STOCK SPLIT WEST PALM BEACH, Fla. – Rennova Health, Inc. , today announced that effective at 5:00 pm, Eastern Time, on March 15, 2022 , the Company completed a 1 for 10,000 reverse stock split of its outstanding common stock. The Company’ s common stock will open for trading on Wednesday March 16, 2022, on a post-split basis and trade under the symbol RNVAD for 20 days. As a result of the reverse stock split, every 10,000 shares of the Company’ s common stock issued and outstanding on the Effective Time will be consolidated into one issued and outstanding share, except to the extent that the reverse stock split results in any of the Company’ s stockholders owning a fractional share, which fractional share will be in that case paid in cash. In connecti..."
03/10/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
02/01/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "FORM OF SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of January 31, 2022, between Rennova Health, Inc., a Delaware corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4 of the Securities Act , and Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement. NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and..."
12/17/2021 8-K Submission of Matters to a Vote of Security Holders, Other Events  Interactive Data
12/13/2021 8-K Quarterly results
11/08/2021 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu...
Docs: "WHEREAS, the certificate of incorporation of the Corporation provides for a class of its authorized stock known as preferred stock, consisting of 5,000,000 shares, $0.01 par value per share, issuable from time to time in one or more series; WHEREAS, the Board of Directors is authorized to fix the dividend rights, dividend rate, voting rights, conversion rights, rights and terms of redemption and liquidation preferences of any wholly unissued preferred stock and the number of shares constituting any series and the designation thereof, of any of them; and",
"CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION OF RENNOVA HEALTH, INC. It is hereby certified that: 1. The name of the corporation is Rennova Health, Inc. , a corporation duly organized and existing under the General Corporation Law of the State of Delaware . 2. The Certificate of Incorporation of the Corporation, as amended, is hereby amended by deleting Article FOURTH, Paragraph A thereof and inserting in lieu of said Paragraph the following new Article FOURTH, Paragraph A: “The total number of shares of all classes of capital stock which the Corporation shall have authority to issue is fifty billion five million shares, comprised of fifty billion shares of Common Stock, par value $.0001 per share, and five million shares of Preferred Stock, par value $0.01 per share. The desig...",
"Form of Exchange and Amendment Agreement, among Rennova Health, Inc., Christopher Diamantis and the investor signatory thereto"
10/28/2021 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "FORM OF SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of October 28, 2021, between Rennova Health, Inc., a Delaware corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4 of the Securities Act , and Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement. NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and..."
10/04/2021 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events  Interactiv...
09/08/2021 8-K Quarterly results
09/02/2021 8-K Quarterly results
08/13/2021 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities
07/19/2021 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Certificate of Amendment to Certificate of Incorporation of Rennova Health, Inc",
"RENNOVA HEALTH, INC. COMPLETES REVERSE STOCK SPLIT WEST PALM BEACH, Fla. – Rennova Health, Inc. , today announced that effective at 5:00 pm, Eastern Time, on July 16, 2021 , the Company effected a 1 for 1,000 reverse stock split of its outstanding common stock. The Company’ s common stock will open for trading on Monday, July 19, 2021 on a post-split basis under the temporary trading symbol “RNVAD”. The trading symbol will revert to “RNVA” after 20 business days."
07/16/2021 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities
07/13/2021 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "RENNOVA HEALTH, INC., DISCUSSES THE COMPLETION OF THE SEPARATION OF ITS SOFTWARE DIVISION AND UPCOMING 10-Q WITH THE STOCK DAY PODCAST WEST PALM BEACH, Fla. – Rennova Health, Inc. , joined Stock Day host Everett Jolly to provide an update on the business and the timing to file the second quarter financial statements.",
"Transcript of Interview of Seamus Lagan"
07/12/2021 8-K Quarterly results
07/01/2021 8-K Quarterly results
06/28/2021 8-K Quarterly results
06/17/2021 8-K Quarterly results
05/24/2021 8-K Quarterly results
05/11/2021 8-K Quarterly results
04/27/2021 8-K Quarterly results
02/05/2021 8-K Quarterly results
12/10/2020 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "rennova health discusses BUSINESS UPDATE with the stock day podcast WEST PALM BEACH, Fla. – Rennova Health, Inc. , , an owner and operator of rural hospitals in Tennessee, announces that Rennova CEO and President of the Company, Seamus Lagan, joined Stock Day host Everett Jolly for a business update. Jolly began the interview by asking about the difficulties the rural healthcare industry is facing during the COVID-19 pandemic. Lagan explained that these difficulties include a reduction in revenue from scheduled visits and services, as well as increased costs associated with implementing visitor and staff safety, and acquiring protective equipment. “More recently, we’ re seeing a lot more competition for staff, which is creating an additional strain on small hospitals,” said Lagan, adding t...",
"Transcript of Interview of Seamus Lagan"
09/01/2020 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy